<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AClayton_Act</id>
	<title>Definition:Clayton Act - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AClayton_Act"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Clayton_Act&amp;action=history"/>
	<updated>2026-05-03T10:27:25Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Clayton_Act&amp;diff=12739&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Clayton_Act&amp;diff=12739&amp;oldid=prev"/>
		<updated>2026-03-13T12:06:53Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🏛️ &amp;#039;&amp;#039;&amp;#039;Clayton Act&amp;#039;&amp;#039;&amp;#039; is a landmark piece of United States federal antitrust legislation, enacted in 1914, that strengthened earlier competition law and has specific relevance to the American insurance industry through its regulation of mergers, acquisitions, and anti-competitive practices. While the [[Definition:McCarran-Ferguson Act | McCarran-Ferguson Act]] of 1945 granted insurers a limited exemption from federal antitrust law — deferring regulatory authority to the states — the Clayton Act&amp;#039;s provisions regarding mergers, exclusive dealing, and interlocking directorates can still apply to insurance transactions, particularly when state regulation does not adequately address the competitive concern in question. For insurance holding companies pursuing acquisitions of carriers, [[Definition:Managing general agent (MGA) | MGAs]], or distribution platforms, Clayton Act review by the Federal Trade Commission or the Department of Justice remains a practical consideration alongside state [[Definition:Insurance regulatory authority | insurance department]] approvals.&lt;br /&gt;
&lt;br /&gt;
⚖️ The Act operates by prohibiting specific business practices that may substantially lessen competition or tend to create a monopoly. Section 7 — its most frequently invoked provision — gives federal authorities the power to block mergers and acquisitions that would concentrate market power excessively, a standard applied in insurance through the Hart-Scott-Rodino pre-merger notification process when transaction thresholds are met. Section 3 addresses exclusive dealing and tying arrangements, which can arise in insurance distribution when a carrier attempts to prevent an [[Definition:Insurance agent | agent]] or [[Definition:Insurance broker | broker]] from placing business with competitors. The interplay between the Clayton Act and the McCarran-Ferguson exemption has been litigated extensively; courts have generally held that the exemption shields the &amp;quot;business of insurance&amp;quot; — such as [[Definition:Underwriting | underwriting]] and [[Definition:Ratemaking | ratemaking]] — but does not necessarily protect ancillary commercial activities like mergers or coercive distribution practices.&lt;br /&gt;
&lt;br /&gt;
📌 For insurance industry participants, the Clayton Act&amp;#039;s significance lies primarily in its role as a check on market consolidation. The ongoing wave of [[Definition:Mergers and acquisitions (M&amp;amp;A) | mergers and acquisitions]] among U.S. carriers, [[Definition:Insurance broker | brokerages]], and [[Definition:Insurtech | insurtech]] firms means that Clayton Act scrutiny is a routine part of deal-making. When major brokerage consolidations have raised concerns about reduced competition in specific commercial lines or geographic markets, the Act provides the legal framework for regulatory challenge. Outside the United States, equivalent competition regimes — such as the European Union&amp;#039;s merger regulation or the UK Competition and Markets Authority&amp;#039;s review powers — serve analogous functions in their respective insurance markets, though the Clayton Act itself applies only within the U.S. jurisdiction.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:McCarran-Ferguson Act]]&lt;br /&gt;
* [[Definition:Antitrust]]&lt;br /&gt;
* [[Definition:Mergers and acquisitions (M&amp;amp;A)]]&lt;br /&gt;
* [[Definition:Insurance regulatory authority]]&lt;br /&gt;
* [[Definition:Market concentration]]&lt;br /&gt;
* [[Definition:Hart-Scott-Rodino Act]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>